Literature DB >> 2760846

Correlation between the inhibitory effect on catecholaminergic ventrolateral medullary neurons and the hypotension evoked by clonidine: a voltammetric approach.

E Tibirica1, C Mermet, J Feldman, F Gonon, P Bousquet.   

Abstract

Neuronal activity was monitored in vivo by differential voltammetry, an electrochemical technique measuring the metabolism of catecholamines. This technique was used to determine the influence of low doses of clonidine (starting from 2 micrograms/kg i.v.) on the activity of the catecholaminergic neurons of the nucleus reticularis lateralis region, site of its hypotensive action, and of the locus ceruleus, which is involved in its sedative effect. There was a correlation between the hypotensive effect of low doses of clonidine (2, 5 and 10 micrograms/kg i.v.) and the decrease of the neuronal metabolic activity within the ventrolateral medulla, whereas only higher doses of clonidine (50 micrograms/kg i.v.) decreased the metabolic activity in the locus ceruleus. Thus, we demonstrate in vivo differences in sensitivity toward the same drug of two different neuronal structures that are involved in the regulation of the cardiovascular and wakefulness functions, respectively. The present study also shows that clonidine has a preferential action on a medulla oblongata region that contains imidazoline-preferring receptors, namely the nucleus reticularis lateralis region, rather than on the locus ceruleus region, that contains mainly alpha-2 adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760846

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

Review 1.  Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.

Authors:  P Bousquet; J Feldman
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 2.  Role of Alcohol Oxidative Metabolism in Its Cardiovascular and Autonomic Effects.

Authors:  Mahmoud M El-Mas; Abdel A Abdel-Rahman
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 3.  Moxonidine. A review of its pharmacology, and therapeutic use in essential hypertension.

Authors:  P Chrisp; D Faulds
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

4.  The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1 imidazoline agonist, moxonidine.

Authors:  S B Penner; D D Smyth
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Central and renal I1 imidazoline preferring receptors: two unique sites mediating natriuresis in the rat.

Authors:  S B Penner; D D Smyth
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

6.  Sodium excretion following central administration of an I1 imidazoline receptor agonist, moxonidine.

Authors:  S B Penner; D D Smyth
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

7.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

8.  Comparison in Conscious Rabbits of the Baroreceptor-Heart Rate Reflex Effects of Chronic Treatment with Rilmenidine, Moxonidine, and Clonidine.

Authors:  Monique L Parkin; Kyungjoon Lim; Sandra L Burke; Geoffrey A Head
Journal:  Front Physiol       Date:  2016-11-15       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.